Author

S. Miyashita

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Evolutionary Biology· 1 Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Organism:non-human primate· 1 Organism:plant (other)· 1 Assay:proteomics· 1 Organism:virus· 1

Frequent Co-Authors

F. Qu· 2 shared J. Han· 2 shared R. Ren· 2 shared A. A. Gumerova· 1 shared A. Macdonald· 1 shared A. Padilla· 1 shared A. Teunissen· 1 shared C. J. Rosen· 1 shared

Activity by Year

2022-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersEvolutionary Biology

F. Qu

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Single-cell mutation rate of turnip crinkle virus (-)-strand replication intermediates

C. P. Carvalho, J. Han, K. Khemson, R. Ren, L. E. A. Camargo, S. Miyashita, F. Qu

This study estimates the mutation rate of turnip crinkle virus (-)-strand replication intermediates in single cells and supports the BIAS replication model.

bioRxiv · May 3, 2023Evolutionary Biology

A small DNA virus initiates replication with no more than three genome copies per cell

R. Ren, L. Zheng, C. Perdoncini Carvalho, J. Han, S. Miyashita, D. Zhang, F. Qu

This study shows DNA viruses like TYLCV undergo intracellular population bottlenecks, limiting replication to no more than three genome copies per cell, ensuring lethal mutations are purged.

bioRxiv · May 27, 2022 · PreprintMicrobiology

A Single Multipurpose FSH-Blocking Therapeutic for Osteoporosis and Obesity

S. Gera, T.-C. Kuo, F. Korkmaz, D. Sant, V. DeMambro, A. A. Gumerova, K. Sudha, A. Padilla, G. Prevot, J. Munitz, A. Teunissen, M. M. T. van Leent, T. G. J. M. Post, J. C. Fernandes, J. Netto, , M. Zaidi

This paper develops and tests a first-in-class FSH-blocking antibody, MS-Hu6, showing efficacy in preventing obesity and osteoporosis in mice and safety in monkeys.

bioRxiv · Feb 28, 2022 · PreprintPharmacology & Toxicology